Design evaluation and optimization for models of hepatitis C viral dynamics

被引:14
作者
Guedj, Jeremie [1 ]
Bazzoli, Caroline [3 ,4 ]
Neumann, Avidan U. [2 ,5 ]
Mentre, France [3 ,4 ]
机构
[1] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[2] Bar Ilan Univ, Everard & Mina Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel
[3] INSERM, UMR 738, F-75018 Paris, France
[4] Univ Paris Diderot, F-75018 Paris, France
[5] Santa Fe Inst, Santa Fe, NM 87501 USA
基金
以色列科学基金会;
关键词
design evaluation; design optimization; hepatitis C; non-linear mixed effect models; ordinary differential equations; viral kinetics; MIXED-EFFECTS MODELS; FISHER INFORMATION MATRIX; IDENTIFIABILITY; KINETICS; STANDARD; ALPHA-2A;
D O I
10.1002/sim.4191
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mathematical modeling of hepatitis C viral (HCV) kinetics is widely used for understanding viral pathogenesis and predicting treatment outcome. The standard model is based on a system of five non-linear ordinary differential equations (ODE) that describe both viral kinetics and changes in drug concentration after treatment initiation. In such complex models parameter estimation is challenging and requires frequent sampling measurements on each individual. By borrowing information between study subjects, non-linear mixed effect models can deal with sparser sampling from each individual. However, the search for optimal designs in this context has been limited by the numerical difficulty of evaluating the Fisher information matrix (FIM). Using the software PFIM, we show that a linearization of the statistical model avoids most of the computational burden, while providing a good approximation to the FIM. We then compare the precision of the parameters that can be expected using five study designs from the literature. We illustrate the usefulness of rationalizing data sampling by showing that, for a given level of precision, optimal design could reduce the total number of measurements by up 50 per cent. Our approach can be used by a statistician or a clinician aiming at designing an HCV viral kinetics study. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:1045 / 1056
页数:12
相关论文
共 38 条
  • [1] Atkinson AC, 1992, OPTIMUM EXPT DESIGNS, DOI [10.1007/978-3-642-04898-2_434, DOI 10.1007/978-3-642-04898-2_434]
  • [2] Peginterferon alpha-2a Is Associated with Higher Sustained Virological Response than Peginterferon alfa-2b in Chronic Hepatitis C: Systematic Review of Randomized Trials
    Awad, Tahany
    Thorlund, Kristian
    Hauser, Goran
    Stimac, Davor
    Mabrouk, Mahasen
    Gluud, Christian
    [J]. HEPATOLOGY, 2010, 51 (04) : 1176 - 1184
  • [3] BATES DM, 1980, J ROY STAT SOC B MET, V42, P1
  • [4] Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0
    Bazzoli, Caroline
    Retout, Sylvie
    Mentre, France
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2010, 98 (01) : 55 - 65
  • [5] Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model
    Bazzoli, Caroline
    Retout, Sylvie
    Mentre, France
    [J]. STATISTICS IN MEDICINE, 2009, 28 (14) : 1940 - 1956
  • [6] Bruno R, 2004, ANTIVIR THER, V9, P491
  • [7] Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomes
    Dahari, Harel
    Affonso de Araujo, Evaldo S.
    Haagmans, Bart L.
    Layden, Thomas J.
    Cotler, Scott J.
    Barone, Antonio A.
    Neumann, Avidan U.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 460 - 467
  • [8] Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
    Dixit, NM
    Layden-Almer, JE
    Layden, TJ
    Perelson, AS
    [J]. NATURE, 2004, 432 (7019) : 922 - 924
  • [9] Practical identifiability of HIV dynamics models
    Guedj, J.
    Thiebauta, R.
    Commengesa, D.
    [J]. BULLETIN OF MATHEMATICAL BIOLOGY, 2007, 69 (08) : 2493 - 2513
  • [10] A perspective on modelling hepatitis C virus infection
    Guedj, J.
    Rong, L.
    Dahari, H.
    Perelson, A. S.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2010, 17 (12) : 825 - 833